Cinaciguat Uses, Dosage, Side Effects and more
Cinaciguat is under investigation in clinical trial NCT01067859 (A Phase Iib Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 ΜG/h, 10 ΜG/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)).
| Trade Name | Cinaciguat |
| Generic | Cinaciguat |
| Cinaciguat Other Names | Cinaciguat |
| Type | |
| Formula | C36H39NO5 |
| Weight | Average: 565.71 Monoisotopic: 565.28282336 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
